Relationship between B-type natriuretic peptide and short-term prognosis in nondiabetic patients with ST-segment elevation myocardial infarction

Peng WEI,Qiang FU,Yan-jiong WANG,Qiang WU,Hai-bo WANG,Wen LU,Jie BAI,Qian ZHANG,Jian ZHONG

DOI: https://doi.org/10.3969/j.1674-4055.2014.03.30

2014-01-01

Abstract:Objective To investigate the difference in the level of B-type natriuretic peptide (BNP) and relationship between BNP and short-term prognosis in the patients with ST-segment elevation myocardial infarction (STEMI). Methods The patients with STEMI [n=124, firstly being hospitalized and accepting coronary angiography (CAG)] were chosen from the Central Hospital of Xuzhou City, and according to the outcomes of ECG and CAG, they were divided into group A (n=53), group B (n=41) and group C (n=30), and other patients with normal CAG (n=30) were chosen as group D (control group). The level of BNP was compared among all groups. All patients were divided again, according to the level of BNP, into normal BNP group (<100 ng/mL, n=36), mild-higher BNP group (100-400 ng/mL, n=61 group) and marked-higher BNP group (≥400 ng/mL, n=27). The incidence of major adverse cardiovascular events (MACE, including secondary heart failure, severe arrhythmia, post-infarction angina, relapse myocardial infarction and cardiac death) was compared among all groups within 6 months. Results The level of BNP showed a gradual decreasing trend [(305.17±112.63) pg/mL, (201.38±72.54) pg/mL, (157.43±79.18) pg/mL, (39.49±15.07) pg/mL] in group A, group B, group C and group D (P<0.05). The comparison in MACE incidence showed that there was no statistical difference between normal BNP group and mild-higher BNP group (P>0.05), and there was statistical difference among all other BNP groups (P<0.05). The incidence of MACE showed an increasing trend in normal BNP group, mild-higher BNP group and marked-higher BNP group. Conclusion The level of BNP can be taken as a clinical index for reviewing the short-term prognosis in the patients with STEMI.